<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010279/" ref="ordinalpos=1972&amp;ncbi_uid=2867876&amp;link_uid=PMC3010279" image-link="/pmc/articles/PMC3010279/figure/F8/" class="imagepopup">Figure 8. Proposed <span class="highlight" style="background-color:">pathway</span> for morphine-induced enhancement of GIRK <span class="highlight" style="background-color:">signaling</span> in hippocampal neurons.  From: Morphine- and CaMKII dependent enhancement of GIRK channel <span class="highlight" style="background-color:">signaling</span> in hippocampal neurons. </a></div><br /><div class="p4l_captionBody"><b>A</b>) Inhibition of intracellular Ca2+ with 50 µm BAPTA-AM prevents the morphine-induced colocalization of GIRK2 and PSD95 in 20 DIV hippocampal neurons (left graph). Exposure to the metabotropic glutamate receptor agonist ACPD (100 µm) for 20 h increases the colocalization ratio for GIRK2 and PSD95 in 20 DIV hippocampal neurons (right graph). <b>B</b>) Schematic shows proposed signaling pathways for morphine and ACPD-dependent upregulation of GIRK2 in hippocampal neurons.</div></div>